2017
DOI: 10.1016/j.biomaterials.2017.08.021
|View full text |Cite
|
Sign up to set email alerts
|

Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
44
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(45 citation statements)
references
References 29 publications
1
44
0
Order By: Relevance
“…Recently, a wide variety of biodegradable polymers has been studied for the co-delivery of several anticancer drugs, including those based on Pt(II) drugs. [266][267][268] It should also be noted a gratype polypeptide micellar system for the combined drug delivery (Fig. 41).…”
Section: Metallopolymers For Combination Therapymentioning
confidence: 99%
“…Recently, a wide variety of biodegradable polymers has been studied for the co-delivery of several anticancer drugs, including those based on Pt(II) drugs. [266][267][268] It should also be noted a gratype polypeptide micellar system for the combined drug delivery (Fig. 41).…”
Section: Metallopolymers For Combination Therapymentioning
confidence: 99%
“…According to the authors, this decrease could be justified by the antioxidant activity in the organism, becoming able to modify the in vivo antioxidant capacity of cells present in plasma and blood. In vitro and in vivo studies by Li et al 45 demonstrated strong evidence that GST inhibitor modified prodrugs combined with nanoparticles significantly enhanced antitumor effects against cisplatin-resistant cancer. Fig.…”
Section: Enzymatic Studiesmentioning
confidence: 99%
“…Another common mechanism of chemoresistance involves glutathione s-transferase (GST) overexpression, an enzyme that typically protects against reactive electrophiles and DNA damage (26). When overexpressed in cancer, GST has been shown to increase chemoresistance, possibly by catalyzing the binding of glutathione to chemotherapy drugs to minimize their effects, preventing drugs from attacking DNA, or deactivating cisplatin, a common platinum-based component of many chemotherapies that targets DNA in cancer cells (6,27,28).…”
Section: Genetic and Functional Adaptation Toward Cell-autonomous Chementioning
confidence: 99%